Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
China flirts with jilted 'Brother Musk' amid breakup with Trump
4/07/2025
‘Unreal’ : Legal experts blast Supreme Court for leaving Trump ‘unrestrained’
4/07/2025
'Humiliation fetish ?' Nancy Mace mocked after Declaration of Independence gaffe
4/07/2025
‘Congratulations America !’ Trump cheers bill CBO says will push 12M off Medicaid
4/07/2025
‘Sick’ : Dems pounce as GOP rep deletes celebration over 18M kids losing meals
4/07/2025
'Generational error' : Analyst warns megabill will 'blow up' key GOP voting bloc
4/07/2025
